Chronic hepatitis B viral (HBV) infection remains a significant global health problem.
Evidence‐based guidelines are needed to help providers determine when treatment should …

Following development of liver cirrhosis in patients with chronic hepatitis B, liver disease
may continue to progress and decompensation or hepatocellular carcinoma (HCC) may …

Background & Aims Large, population-based studies that have included the full spectrum of
cirrhosis estimating survival, taking into account time-at-risk are lacking. We aimed to report …

Hepatitis B is a significant public health problem in India, yet disease awareness is very low
among the general population. The disease is mostly acquired horizontally, but the role of …

Background & Aims Pre-acute-on-chronic liver failure (ACLF) is a distinct intermediate stage
between acute decompensation (AD) and ACLF. However, identifying patients with pre …

Background The complications to chronic hepatitis B (HBV) include incidence of
hepatocellular carcinoma (HCC) and mortality. The risk of these complications may vary in …

OBJECTIVES: The occurrence of decompensation marks a crucial turning point in the
course of cirrhosis. The purpose of this study was to assess the risk of mortality according to …

Chronic infections with the hepatitis B and C viruses have significant worldwide health and
economic impacts. Previous treatments for hepatitis C such as interferon and ribavirin …

Background: Patients with end-stage liver disease (ESLD) have a poor quality of life, which
often worsens as disease severity increases. Palliative care (PC) has emerged as a …

Objectives The effect of antiviral therapy on clinical outcomes in chronic hepatitis B virus
(HBV) is not established. We aimed to assess the effects of interferon and/or nucleos (t) ide …